Citigroup’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$726K Sell
5,625
-6,329
-53% -$910K ﹤0.01% 3316
2025
Q4
$1.71M Sell
11,954
-1,950
-14% -$261K ﹤0.01% 2768
2025
Q3
$1.67M Sell
13,904
-78,535
-85% -$9.95M ﹤0.01% 2823
2025
Q2
$12.2M Sell
92,439
-11,367
-11% -$1.54M 0.01% 1259
2025
Q1
$14.4M Buy
103,806
+71,435
+221% +$11.1M 0.01% 1139
2024
Q4
$5.02M Buy
32,371
+3,406
+12% +$576K ﹤0.01% 1954
2024
Q3
$5.28M Buy
28,965
+14,512
+100% +$2.15M ﹤0.01% 1802
2024
Q2
$1.72M Sell
14,453
-22,717
-61% -$2.39M ﹤0.01% 2469
2024
Q1
$3.99M Buy
37,170
+15,840
+74% +$1.57M ﹤0.01% 1884
2023
Q4
$2.13M Buy
21,330
+15,157
+246% +$1.48M ﹤0.01% 2190
2023
Q3
$735K Buy
6,173
+4,835
+361% +$721K ﹤0.01% 2766
2023
Q2
$238K Sell
1,338
-2,920
-69% -$536K ﹤0.01% 3805
2023
Q1
$702K Buy
4,258
+1,305
+44% +$225K ﹤0.01% 2856
2022
Q4
$465K Sell
2,953
-2,266
-43% -$345K ﹤0.01% 3231
2022
Q3
$787K Buy
5,219
+2,563
+96% +$426K ﹤0.01% 2898
2022
Q2
$438K Sell
2,656
-25,842
-91% -$4.97M ﹤0.01% 3329
2022
Q1
$6.34M Buy
28,498
+3,698
+15% +$828K ﹤0.01% 1544
2021
Q4
$5.89M Buy
24,800
+10,157
+69% +$2.37M ﹤0.01% 1707
2021
Q3
$3.42M Buy
14,643
+8,544
+140% +$1.79M ﹤0.01% 2076
2021
Q2
$1.25M Sell
6,099
-3,768
-38% -$775K ﹤0.01% 3047
2021
Q1
$2.03M Buy
9,867
+5,649
+134% +$1.19M ﹤0.01% 2475
2020
Q4
$904K Buy
4,218
+500
+13% +$97K ﹤0.01% 3636
2020
Q3
$679K Sell
3,718
-6,154
-62% -$1.16M ﹤0.01% 3587
2020
Q2
$1.82M Sell
9,872
-1,777
-15% -$353K ﹤0.01% 2918
2020
Q1
$2.35M Buy
11,649
+2,335
+25% +$449K ﹤0.01% 2337
2019
Q4
$1.74M Buy
9,314
+6,066
+187% +$1.04M ﹤0.01% 3146
2019
Q3
$519K Sell
3,248
-366
-10% -$72.9K ﹤0.01% 4305
2019
Q2
$911K Sell
3,614
-4,626
-56% -$1.07M ﹤0.01% 3741
2019
Q1
$1.97M Buy
8,240
+2,439
+42% +$585K ﹤0.01% 2658
2018
Q4
$1.33M Sell
5,801
-4,511
-44% -$1.11M ﹤0.01% 3104
2018
Q3
$2.92M Buy
10,312
+7,192
+231% +$2.11M ﹤0.01% 2377
2018
Q2
$915K Sell
3,120
-1,864
-37% -$509K ﹤0.01% 3446
2018
Q1
$1.26M Sell
4,984
-1,091
-18% -$256K ﹤0.01% 3046
2017
Q4
$1.31M Sell
6,075
-6,205
-51% -$1.26M ﹤0.01% 3072
2017
Q3
$2.28M Sell
12,280
-4,910
-29% -$856K ﹤0.01% 2522
2017
Q2
$2.96M Buy
17,190
+8,775
+104% +$1.41M ﹤0.01% 2173
2017
Q1
$1.29M Sell
8,415
-13,224
-61% -$1.93M ﹤0.01% 2949
2016
Q4
$3.19M Buy
21,639
+11,618
+116% +$1.68M ﹤0.01% 2361
2016
Q3
$1.27M Buy
10,021
+4,155
+71% +$501K ﹤0.01% 2964
2016
Q2
$661K Sell
5,866
-4,623
-44% -$480K ﹤0.01% 3353
2016
Q1
$1.09M Buy
10,489
+8,710
+490% +$833K ﹤0.01% 3236
2015
Q4
$201K Buy
1,779
+1,557
+701% +$172K ﹤0.01% 4739
2015
Q3
$24K Sell
222
-192
-46% -$20.5K ﹤0.01% 5908
2015
Q2
$40K Sell
414
-297
-42% -$27.8K ﹤0.01% 5681
2015
Q1
$66K Sell
711
-88
-11% -$7.7K ﹤0.01% 5341
2014
Q4
$66K Sell
799
-642
-45% -$49.2K ﹤0.01% 5511
2014
Q3
$92K Buy
1,441
+210
+17% +$12.9K ﹤0.01% 4838
2014
Q2
$75K Sell
1,231
-204
-14% -$12K ﹤0.01% 4877
2014
Q1
$86K Sell
1,435
-4,408
-75% -$272K ﹤0.01% 5116
2013
Q4
$372K Sell
5,843
-244
-4% -$15.7K ﹤0.01% 4071
2013
Q3
$414K Buy
6,087
+5,205
+590% +$372K ﹤0.01% 3588
2013
Q2
$64K Buy
+882
New +$58.3K ﹤0.01% 5200

Other funds holding ICUI

Citigroup's ICUI Position: Q1 2026 in Review

Citigroup reduced its ICU Medical (ICUI) stake by 53% in Q1 2026, selling an estimated $910K and leaving 5,625 shares worth $726K. The position accounts for ﹤0.01% of the portfolio, ranked #3316.

Citigroup first reported a position in ICUI in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.4M in Q1 2025. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • Citigroup held 5,625 shares of ICU Medical worth $726K as of Q1 2026.
  • Citigroup sold 6,329 ICU Medical shares in Q1 2026, an estimated $910K.
  • ICU Medical made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3316 holding.
  • Citigroup first reported a position in ICU Medical in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's ICU Medical position peaked at $14.4M in Q1 2025.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.